Pernix Therapeutics Holdings Inc (NASDAQ:PTX) received a letter from Nasdaq stating that, as a result of the appointments of Messrs. Sedor and Konidaris to the Board of Directors and Audit Committee, the Company has regained compliance with the requirements of the Listing Rules. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) net profit margin is -30.20% and weekly performance is 5.52%. On last trading day company shares ended up $4.78. Analysts mean target price for the company is $4.43. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) distance from 50-day simple moving average (SMA50) is 3.47%.
Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm has commenced an investigation intoPrana Biotechnology Limited (ADR) (NASDAQ:PRAN). The investigation is related to potential violations of federal securities laws and other violations. Biotechnology Limited (ADR) (NASDAQ:PRAN) shares advanced 7.69% in last trading session and ended the day on $1.68. Its return on assets is -113.30%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) quarterly performance is -83.06%.
Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the first quarter ended March 31, 2014. The Company had $177.7 million in cash, cash equivalents and marketable securities as of March 31, 2014. Dynavax Technologies Corporation (NASDAQ:DVAX) shares moved up 6.15% in last trading session and was closed at $1.38, while trading in range of $1.30 – $1.41 -. Dynavax Technologies Corporation (NASDAQ:DVAX) year to date (YTD) performance is -29.59%.
MEI Pharma, Inc. (NASDAQ:MEIP) an oncology company focused on the clinical development of novel therapies for cancer, announced that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present investor conferences: The Bank of America Merrill Lynch Health Care Conference on Thursday, May 15, 2014 at 12:40 p.m. Pacific time from the Encore at the Wynn in Las Vegas. MEI Pharma Inc (NASDAQ:MEIP) ended the last trading day at $6.92. Company weekly volatility is calculated as 6.83% and price to cash ratio as 2.50. MEI Pharma Inc (NASDAQ:MEIP) showed a negative weekly performance of -5.85%.
Leave a Reply